Abstract

Human T-cell lymphotropic virus type-1 (HTLV-1) is a pathogenic retrovirus that is associated with adult T-cell leukemia/lymphoma (ATL). Genetic instability is the hallmark of ATL. Cell cycle progression is needed for virus particle reproduction. HTLV-1 encoded Tax protein ultimately disrupts the mitotic spindle checkpoint, leading to incorrect chromosome segregation, resulting in aneuploidy. Cell cycle abnormalities have been described in T cells transfected with HTLV-1 virus in vitro, but not in HTLV-1 asymptomatic carriers. PTTG1 and HTLV-1 viral protein Tax exhibit a cooperative transforming activity. Overexpressed PTTG1 results in chromosome instability and aneuploidy, which has been suggested as a mechanism underlying PTTG1 transforming activity. Here we aimed to investigate cell cycle, DNA ploidy and PTTG1 mRNA expression in CD4+ and CD8+ T cells in healthy subjects (HS), HTLV-1 asymptomatic carriers and ATL patients. We have identified that HTLV-1 asymptomatic carriers have shown DNA aneuploidy and cell cycle arrest at cell cycle phase G0/G1 in CD4+ T cells. CD8+ T cells of HTLV-1 asymptomatic carriers also demonstrated DNA aneuploidy but without alteration in cell cycle. In ATL, CD4+ and CD8+ T cells present a higher number of cells in cell cycle S-phase and PTTG1 overexpression. These studies provide insight into malignant transformation of HTLV-1 asymptomatic carriers to ATL patients.

Highlights

  • Adult T-cell leukemia/lymphoma (ATL) is an aggressive and incurable malignancy of mature CD3+, CD4+, CD25+, CD7− T cells caused by human T-cell lymphotropic virus type-1 (HTLV-1), which was initially described in 1977 by Takatsuki (2005)

  • The percentage of CD4+ T cells in S-phase was significantly higher in adult T-cell leukemia/lymphoma (ATL), with a median of 1.8% (0.0–10.36%; DP 3.37) in healthy subjects with a median of 0.63% (0.0–7.63%; DP 1.78), p = 0.020 and Human T-cell lymphotropic virus type-1 (HTLV-1) infected with a median of 0.34% (0.0– 6.98%; DP 1.27), p < 0.001

  • HTLV-1 infected and healthy subjects did not show any significant difference in the percentage of cells

Read more

Summary

Introduction

Adult T-cell leukemia/lymphoma (ATL) is an aggressive and incurable malignancy of mature CD3+, CD4+, CD25+, CD7− T cells caused by human T-cell lymphotropic virus type-1 (HTLV-1), which was initially described in 1977 by Takatsuki (2005). At least 5–10 million people are infected with HTLV-1 (Gessain and Cassar, 2012). The prevalence varies according to the geographic area, with predominance in southwestern Japan, sub-Saharan Africa, Melanesia, the Caribbean, and HTLV-1 Carriers and ATL Patient’s Alterations. In Brazil, almost 800,000 people are infected with HTLV-1 (Carneiro-Proietti et al, 2002). ATL occurs after a long period of latency, as long as 20–30 years, but the host- or virusrelated factors that influence ATL progression are unknown. The low rate of progression and long latency period suggest that secondary genetic events are important in the oncogenesis of ATL (Marriott and Semmes, 2005)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call